Does Atropine Sulfate Injection Usp 05 Mg07 Ml Interact with Pralidoxime?
Atropine Sulfate Injection Usp 05 Mg07 Ml and Pralidoxime have a moderate drug interaction according to U.S. FDA drug labeling data. Pralidoxime may potentiate the effect of atropine, causing signs of atropinization (flushing, mydriasis, tachycardia, dryness of mouth/nose) to occur earlier than expected. Excitement and manic behavior may follow recovery of consciousness. The mechanism involves pralidoxime potentiates the effect of atropine. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Atropine Sulfate Injection Usp 05 Mg07 Ml Class
- Anticholinergic
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Atropine Sulfate Injection Usp 05 Mg07 Ml and Pralidoxime occurs because pralidoxime potentiates the effect of atropine. Clinically, this means pralidoxime may potentiate the effect of atropine, causing signs of atropinization (flushing, mydriasis, tachycardia, dryness of mouth/nose) to occur earlier than expected. excitement and manic behavior may follow recovery of consciousness. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Atropine Sulfate Injection Usp 05 Mg07 Ml and your doctor is considering prescribing Pralidoxime (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider